Reply to ‘Absence of JAK-2 (Val617Phe) point mutations in multiple myeloma’ by Dr Qin Huang et al. referred to ‘Screening of JAK2 V617F mutation in multiple myeloma’ from Fiorini A et al. published in Leukemia 2006, October 20.

A letter to the editor is presented in response to the article "Absence of JAK-2 (Val617Phe) point mutations in multiple myeloma," by Quin Huang and colleagues in the October 20, 2006 issue.